Doyle Mittie
Chief Medical Officer · 29 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | AVTX | Avalo Therapeutics, Inc. | Sale | 4,654 | $20.00 | $93,080.00 | filing |
| 2026-06-30 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 2,875 | $12.65 | $36,368.75 | filing |
| 2026-06-30 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 1,779 | $8.04 | $14,303.16 | filing |
| 2026-06-23 | AVTX | Avalo Therapeutics, Inc. | Sale | 1,450 | $18.00 | $26,100.00 | filing |
| 2026-06-23 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 1,450 | $8.04 | $11,658.00 | filing |
| 2026-06-10 | AVTX | Avalo Therapeutics, Inc. | Tax withholding | 1,084 | $13.10 | $14,200.40 | filing |
| 2026-05-28 | AVTX | Avalo Therapeutics, Inc. | Sale | 679 | $16.00 | $10,864.00 | filing |
| 2026-05-28 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 679 | $8.04 | $5,459.16 | filing |
| 2026-05-21 | AVTX | Avalo Therapeutics, Inc. | Award | 43,500 | $0.00 | $0.00 | filing |
| 2026-05-15 | AVTX | Avalo Therapeutics, Inc. | Sale | 3,000 | $18.76 | $56,280.00 | filing |
| 2026-05-15 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 3,000 | $12.65 | $37,950.00 | filing |
| 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 77,905 | $12.65 | $985,498.25 | filing |
| 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Sale | 44,944 | $21.20 | $952,668.98 | filing |
| 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Sale | 27,538 | $18.03 | $496,405.50 | filing |
| 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Sale | 19,015 | $22.41 | $426,050.09 | filing |
| 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 28,650 | $8.04 | $230,346.00 | filing |
| 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Sale | 10,058 | $22.88 | $230,127.04 | filing |
| 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Sale | 5,000 | $19.65 | $98,251.00 | filing |
| 2026-05-05 | AVTX | Avalo Therapeutics, Inc. | Sale | 1,679 | $16.00 | $26,864.00 | filing |
| 2026-05-05 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 1,000 | $12.65 | $12,650.00 | filing |
| 2026-05-05 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 679 | $8.04 | $5,459.16 | filing |
| 2026-04-06 | AVTX | Avalo Therapeutics, Inc. | Sale | 3,970 | $18.01 | $71,508.43 | filing |
| 2026-04-06 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 3,970 | $12.65 | $50,220.50 | filing |
| 2026-04-01 | AVTX | Avalo Therapeutics, Inc. | Sale | 679 | $16.00 | $10,864.00 | filing |
| 2026-04-01 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 679 | $8.04 | $5,459.16 | filing |
| 2026-03-16 | AVTX | Avalo Therapeutics, Inc. | Sale | 25,492 | $16.15 | $411,606.58 | filing |
| 2026-03-16 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 19,500 | $12.65 | $246,675.00 | filing |
| 2026-03-16 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 5,992 | $8.04 | $48,175.68 | filing |
| 2025-12-10 | AVTX | Avalo Therapeutics, Inc. | Tax withholding | 1,013 | $4.10 | $4,153.30 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.